101P Safety and effectiveness of pembrolizumab combined with albumin-bound paclitaxel and nedaplatin as first-line treatment in advanced esophageal squamous cell carcinoma patients. (December 2022) - Yan, F.; Ying, M.; Chen, L.; Fu, Q.